1
|
Kitching R, Li H, Wong MJ, Kanaganayakam
S, Kahn H and Seth A: Characterization of a novel human breast
cancer associated gene (BCA3) encoding an alternatively spliced
proline-rich protein. Biochim Biophys Acta. 1625:116–121. 2003.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Sastri M, Barraclough DM, Carmichael PT
and Taylor SS: A-kinase-interacting protein localizes protein
kinase A in the nucleus. Proc Natl Acad Sci USA. 102:349–354. 2005.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Gao N, Asamitsu K, Hibi Y, Ueno T and
Okamoto T: AKIP1 enhances NF-kappaB-dependent gene expression by
promoting the nuclear retention and phosphorylation of p65. J Biol
Chem. 283:7834–7843. 2008. View Article : Google Scholar : PubMed/NCBI
|
4
|
Gao N, Hibi Y, Cueno M, Asamitsu K and
Okamoto T: A-kinase-interacting protein 1 (AKIP1) acts as a
molecular determinant of PKA in NF-kappaB signaling. J Biol Chem.
285:28097–28104. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
King CC, Sastri M, Chang P, Pennypacker J
and Taylor SS: The rate of NF-κB nuclear translocation is regulated
by PKA and A kinase interacting protein 1. PLoS One. 6:e187132011.
View Article : Google Scholar
|
6
|
Leon DA and Cànaves JM: In silico study of
breast cancer associated gene 3 using LION Target Engine and other
tools. Biotechniques. 35:1222–1226. 12281230–1231. 2003.PubMed/NCBI
|
7
|
Leung TH and Ngan HY: Interaction of TAp73
and breast cancer-associated gene 3 enhances the sensitivity of
cervical cancer cells in response to irradiation-induced apoptosis.
Cancer Res. 70:6486–6496. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Qin HY and Han H: Effect of KyoT2 binding
protein KBP1 on RBP-J-mediated transcriptional activity. Xi Bao Yu
Fen Zi Mian Yi Xue Za Zhi. 20:544–547. 2004.In Chinese. PubMed/NCBI
|
9
|
Gao F, Cheng J, Shi T and Yeh ET:
Neddylation of a breast cancer-associated protein recruits a class
III histone deacetylase that represses NFkappaB-dependent
transcription. Nat Cell Biol. 8:1171–1177. 2006. View Article : Google Scholar : PubMed/NCBI
|
10
|
Sastri M, Haushalter KJ, Panneerselvam M,
Chang P, Fridolfsson H, Finley JC, Ng D, Schilling JM, Miyanohara
A, Day ME, et al: A kinase interacting protein (AKIP1) is a key
regulator of cardiac stress. Proc Natl Acad Sci USA. 110:E387–E396.
2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Hashimoto M, Murata E and Aoki T:
Secretory protein with RING finger domain (SPRING) specific to
Trypanosoma cruzi is directed, as a ubiquitin ligase related
protein, to the nucleus of host cells. Cell Microbiol. 12:19–30.
2010. View Article : Google Scholar
|
12
|
Yu KP, Itokawa T, Zhu ML, Syam S, Seth A
and Insogna K: Breast cancer-associated gene 3 (BCA3) is a novel
Rac1-interacting protein. J Bone Miner Res. 22:628–637. 2007.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Sakai H, Chen Y, Itokawa T, Yu KP, Zhu ML
and Insogna K: Activated c-Fms recruits Vav and Rac during
CSF-1-induced cytoskeletal remodeling and spreading in osteoclasts.
Bone. 39:1290–1301. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Diebold I, Djordjevic T, Hess J and
Görlach A: Rac-1 promotes pulmonary artery smooth muscle cell
proliferation by upregulation of plasminogen activator inhibitor-1:
role of NFkappaB-dependent hypoxia-inducible factor-1alpha
transcription. Thromb Haemost. 100:1021–1028. 2008.
|
15
|
Williams LM, Lali F, Willetts K, Balague
C, Godessart N, Brennan F, Feldmann M and Foxwell BM: Rac mediates
TNF-induced cytokine production via modulation of NF-kappaB. Mol
Immunol. 45:2446–2454. 2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
Yu M, Qi X, Moreno JL, Farber DL and
Keegan AD: NF-κB signaling participates in both RANKL- and
IL-4-induced macrophage fusion: Receptor cross-talk leads to
alterations in NF-κB pathways. J Immunol. 187:1797–1806. 2011.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Yamashita T, Yao Z, Li F, Zhang Q, Badell
IR, Schwarz EM, Takeshita S, Wagner EF, Noda M, Matsuo K, et al:
NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB
ligand (RANKL) and tumor necrosis factor-induced osteoclast
precursor differentiation by activating c-Fos and NFATc1. J Biol
Chem. 282:18245–18253. 2007. View Article : Google Scholar : PubMed/NCBI
|
18
|
Valenzuela DM, Murphy AJ, Frendewey D,
Gale NW, Economides AN, Auerbach W, Poueymirou WT, Adams NC, Rojas
J, Yasenchak J, et al: High-throughput engineering of the mouse
genome coupled with high-resolution expression analysis. Nat
Biotechnol. 21:652–659. 2003. View
Article : Google Scholar : PubMed/NCBI
|
19
|
Copeland NG, Jenkins NA and Court DL:
Recombineering: A powerful new tool for mouse functional genomics.
Nat Rev Genet. 2:769–779. 2001. View
Article : Google Scholar : PubMed/NCBI
|
20
|
Liu P, Jenkins NA and Copeland NG: A
highly efficient recombineering-based method for generating
conditional knockout mutations. Genome Res. 13:476–484. 2003.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Sarov M, Schneider S, Pozniakovski A,
Roguev A, Ernst S, Zhang Y, Hyman AA and Stewart AF: A
recombineering pipeline for functional genomics applied to
Caenorhabditis elegans. Nat Methods. 3:839–844. 2006. View Article : Google Scholar : PubMed/NCBI
|
22
|
Rohrschneider LR, Rothwell VM and Nicola
NA: Transformation of murine fibroblasts by a retrovirus encoding
the murine c-fms proto-oncogene. Oncogene. 4:1015–1022.
1989.PubMed/NCBI
|
23
|
Lacey DL, Timms E, Tan HL, Kelley MJ,
Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S,
et al: Osteoprotegerin ligand is a cytokine that regulates
osteoclast differentiation and activation. Cell. 93:165–176. 1998.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Yao GQ, Wu JJ, Troiano N, Zhu ML, Xiao XY
and Insogna K: Selective deletion of the membrane-bound colony
stimulating factor 1 isoform leads to high bone mass but does not
protect against estrogen-deficiency bone loss. J Bone Miner Metab.
30:408–418. 2012. View Article : Google Scholar
|
25
|
Kawano T, Zhu M, Troiano N, Horowitz M,
Bian J, Gundberg C, Kolodziejczak K and Insogna K: LIM kinase 1
deficient mice have reduced bone mass. Bone. 52:70–82. 2013.
View Article : Google Scholar :
|
26
|
Perona R, Montaner S, Saniger L,
Sánchez-Pérez I, Bravo R and Lacal JC: Activation of the nuclear
factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev.
11:463–475. 1997. View Article : Google Scholar : PubMed/NCBI
|
27
|
Montaner S, Perona R, Saniger L and Lacal
JC: Multiple signalling pathways lead to the activation of the
nuclear factor kappaB by the Rho family of GTPases. J Biol Chem.
273:12779–12785. 1998. View Article : Google Scholar : PubMed/NCBI
|
28
|
Miyazaki T, Katagiri H, Kanegae Y,
Takayanagi H, Sawada Y, Yamamoto A, Pando MP, Asano T, Verma IM,
Oda H, et al: Reciprocal role of ERK and NF-kappaB pathways in
survival and activation of osteoclasts. J Cell Biol. 148:333–342.
2000. View Article : Google Scholar : PubMed/NCBI
|
29
|
Ogasawara T1, Katagiri M, Yamamoto A,
Hoshi K, Takato T, Nakamura K, Tanaka S, Okayama H and Kawaguchi H:
Osteoclast differentiation by RANKL requires NF-kappaB-mediated
down-regulation of cyclin-dependent kinase 6 (Cdk6). J Bone Miner
Res. 19:1128–1136. 2004. View Article : Google Scholar : PubMed/NCBI
|
30
|
Yao C, Yao GQ, Sun BH, Zhang C, Tommasini
SM and Insogna K: The transcription factor T-box3 regulates colony
stimulating factor 1-dependent Jun dimerization protein 2
expression and plays an important role in osteoclastogenesis. J
Biol Chem. 289:6775–6790. 2014. View Article : Google Scholar : PubMed/NCBI
|
31
|
Lloyd SA, Yuan YY, Kostenuik PJ, Ominsky
MS, Lau AG, Morony S, Stolina M, Asuncion FJ and Bateman TA:
Soluble RANKL induces high bone turnover and decreases bone volume,
density, and strength in mice. Calcif Tissue Int. 82:361–372. 2008.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Frost JA, Swantek JL, Stippec S, Yin MJ,
Gaynor R and Cobb MH: Stimulation of NFkappa B activity by multiple
signaling pathways requires PAK1. J Biol Chem. 275:19693–19699.
2000. View Article : Google Scholar : PubMed/NCBI
|
33
|
Boyer L, Travaglione S, Falzano L,
Gauthier NC, Popoff MR, Lemichez E, Fiorentini C and Fabbri A: Rac
GTPase instructs nuclear factor-kappaB activation by conveying the
SCF complex and IkBalpha to the ruffling membranes. Mol Biol Cell.
15:1124–1133. 2004. View Article : Google Scholar :
|
34
|
Michaelson D, Abidi W, Guardavaccaro D,
Zhou M, Ahearn I, Pagano M and Philips MR: Rac1 accumulates in the
nucleus during the G2 phase of the cell cycle and promotes cell
division. J Cell Biol. 181:485–496. 2008. View Article : Google Scholar : PubMed/NCBI
|
35
|
van Hennik PB, ten Klooster JP, Halstead
JR, Voermans C, Anthony EC, Divecha N and Hordijk PL: The
C-terminal domain of Rac1 contains two motifs that control
targeting and signaling specificity. J Biol Chem. 278:39166–39175.
2003. View Article : Google Scholar : PubMed/NCBI
|
36
|
Sandrock K, Bielek H, Schradi K, Schmidt G
and Klugbauer N: The nuclear import of the small GTPase Rac1 is
mediated by the direct interaction with karyopherin alpha2.
Traffic. 11:198–209. 2010. View Article : Google Scholar
|
37
|
Vaira S, Alhawagri M, Anwisye I, Kitaura
H, Faccio R and Novack DV: RelA/p65 promotes osteoclast
differentiation by blocking a RANKL-induced apoptotic JNK pathway
in mice. J Clin Invest. 118:2088–2097. 2008.PubMed/NCBI
|
38
|
Ikeda F, Matsubara T, Tsurukai T, Hata K,
Nishimura R and Yoneda T: JNK/c-Jun signaling mediates an
anti-apoptotic effect of RANKL in osteoclasts. J Bone Miner Res.
23:907–914. 2008. View Article : Google Scholar : PubMed/NCBI
|